Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: The influence of neoadjuvant treatment

Background: This study was conducted in order to clarify whether histopatho logic analysis of factor thymidine phosphorylase (TP) and Factor VIII could be a useful predictor of postoperative recurrence in localized renal cell carcinoma. Therefore, the relationship between tumor infiltrated lymphocyte s (TIL) and both TP and Factor VIII was studied. Method: Of the 71 patients who underwent surgery, 54 patients had no neoadj uvant therapy (group 1), 10 patients were preoperatively administered IFN-g amma (group 2), and the remaining seven patients preoperatively received IF N-gamma and transarterial embolization (group 3). Both TP and Factor VIII i mmunostaining were performed on formalin-fixed, paraffin-embedded archival tissue from 71 renal cell carcinoma specimens, while TIL immunostaining was performed on frozen sections. Positive immunostaining was quantitatively s cored by a computer-assisted digital image analysis. For TIL, positive resu lts were semiquantitatively scored. Results: A significant difference in the recurrence-free rate was recognize d for Groups 1, 2 and 3 (P < 0.05). Therefore, the median TP-positive rate (PR), VIII-PR, number of microvessels and positive mean vascular area level s were investigated, between the recurrence cases (n = 6) and the recurrenc e-free cases (n = 11). Only the TP-PR levels showed a significant differenc e among them (P = 0.044). In regards to the neoadjuvant cases, a significan t correlation was observed between both VIII-PR and CD4 (r = 0.815) as well as between VIII-PR and CD11b (r = 0.756). Conclusion: There was no clear evidence that the neoadjuvant treatment woul d increase the recurrence-free survival in patients with localized renal ce ll carcinoma. TP-PR might be a predictor of postoperative recurrence in pat ients with localized renal cell carcinoma.